SMLR Prakiraan rega marang bathi Semler Scientific Inc

Semler Scientific, Inc. (SMLR) develops vascular analysis systems, while outsourcing the production of hardware modules and global services to third-party contractors. Market price action indicates that the current P/E ratio is 0.00. Market capitalization growth is supported by the sale of diagnostic complexes and the aggressive acquisition of cryptocurrency for the balance sheet, while the potential of new software is only beginning to unfold.

SMLR - Kapitalisasi marang proyeksi bathi semlerscientific.com ing rentang 04.07.2022 - 31.01.2026

Rincian metrik keuangan lan pasar Semler (SMLR)

- nilai saham lan prakiraan konsensus rega:

Bagan rega Semler Scientific|SMLR - Target median analis

- data kapitalisasi pasar:

Biji pasar Semler Scientific Inc|SMLR - Total Nilai Bisnis

- statistik nilai buku emiten:

Nilai Buku saben Saham Semler Scientific|SMLR - Pambiji Buku Bisnis|Rasio Kapitalisasi Pasar marang Nilai Buku semlerscientific.com|SMLR - Gunggung Aset Perusahaan

- informasi babagan utang lan solvabilitas:

Rasio Total Utang marang Ekuitas Semler Scientific, Inc.|SMLR - Koefisien utang jangka dawa marang modal|Utang jangka cendhak marang ekuitas Semler Scientific, Inc.|SMLR - Gunggung utang perusahaan|Utang-utang marang kapitalisasi buku Semler Scientific Inc|SMLR - Utang jangka dawa|Utang jangka cendhak perusahaan Semler Scientific|Rasio cepet semlerscientific.com

- statistik bathi lan rasio pasar:

SMLR - Asil keuangan resik|Proyeksi bathi mangsa ngarep Semler Scientific, Inc.|SMLR - Koefisien rega marang bathi|Pangali Forward P/E Semler Scientific Corp|SMLR - Pangali PEG|Nilai perusahaan marang bathi sadurunge bunga, pajeg, lan panyusutan Semler Scientific Inc|SMLR - Bathi sadurunge mbayar bunga, pajak, lan amortisasi|Bathi resik saben saham sajrone 12 wulan pungkasan Semler Scientific|SMLR - Bathi saben saham sajroning taun lumaku|Wutah bathi EPS kuartalan semlerscientific.com|SMLR - Kacepetan wutah bathi saben saham ing taun lumaku|Prakiraan wutah bathi resik saben saham kanggo taun ngarep Semler Scientific, Inc.

Analisis fundamental perusahaan:Semler Scientific

It is critical for investors to timely identify the risk of overpaying for Semler Scientific, Inc. (SMLR) shares. Robotic manufacturing ensures high vascular diagnostic precision, which minimizes defects and stabilizes margins. The forward P/E trend for Semler Scientific, Inc. (SMLR) reflects the ratio of the current price to projected earnings, allowing for the daily tracking of the asset's fair value. This indicator helps avoid overvaluation without missing growth phases. The business's technological resilience confirms the reliability of these forecasts.

Pesaing Semler Scientific, Inc. (SMLR)

Rega marang bathi mangsa ngarep Abbott (ABT)|Kapitalisasi marang proyeksi bathi Thermo Fisher Scientific Inc.|GE Healthcare Corp - Prakiraan rega marang bathi|Rasio kapitalisasi marang bathi mangsa ngarep MTD (Mettler Toledo Inc)|Waters Corporation - Pangali Forward P/E|Kapitalisasi marang proyeksi bathi bio-techne.com TECH|BRKR: Pangali Forward P/E|Prakiraan rega marang bathi Azenta Inc|Prakiraan rega marang bathi VREX|BFLY: Pangali mangsa ngarep rega marang bathi|Rega marang bathi mangsa ngarep Mesa Laboratories, Inc. (MLAB)|Prakiraan rega marang bathi quantum-si.com QSI|Pangali Forward P/E NNOX (Nano-X)|Quanterix Corp. (QTRX) - Rasio prakiraan rega marang bathi|908 Devices Corp - Pangali Forward P/E|CV (CapsoVision Inc) - Rasio rega marang bathi mangsa ngarep|MXCT: Pangali Forward P/E|RPID - Kapitalisasi marang proyeksi bathi|SEER (Seer) - Pangali Forward P/E|Prakiraan rega marang bathi Hyperfine Inc (HYPR)|Pangali Forward P/E FONR|Pangali Forward P/E daxor.com (DXR)|Rega marang bathi mangsa ngarep Spectral AI MDAI|organovo.com - Rega marang bathi mangsa ngarep|ACON: Prakiraan rega marang bathi|Pangali mangsa ngarep rega marang bathi AKYA (Akoya Biosciences)|THMO: Pangali Forward P/E|Rasio prakiraan rega marang bathi Talis Biomedical Corporation (TLIS)|Rega marang bathi mangsa ngarep T2 Biosystems, Inc.